Search | OpenScholar

Search results

373 results found

Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology 2011;77:767-74.

Publication: Journal Article

Schapira, AH, P Barone, RA Hauser, Y Mizuno, O Rascol, M Busse, L Salin, N Juhel, and . 2011. “Extended-Release Pramipexole in Advanced Parkinson Disease: A Randomized Controlled Trial. Neurology 2011;77:767-74.”. Neurology.

SPECT brain imaging in patients with suspected Parkinsonian syndromes.

Publication: Journal Article

Hauser, RA, and DG Grosset. 2012. “SPECT Brain Imaging in Patients With Suspected Parkinsonian Syndromes.”. J Neuroimaging.

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.

Publication: Journal Article

Olanow, CW, RA Hauser, J Jankovic, W Langston, A Lang, W Poewe, E Tolosa, et al. 2008. “A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline As a Disease Modifying Therapy in Parkinson’s Disease (the ADAGIO Study): Rationale, Design, and Baseline Characteristics.”. Mov Disord.

Tiagabine and exacerbation of essential tremor.

Publication: Journal Article

Zesiewicz, TA, CL Ward, and RA Hauser. 2007. “Tiagabine and Exacerbation of Essential Tremor.”. Mov Disord.

Role of the pharmacist in the effective management of wearing-off in Parkinson’s disease.

Publication: Journal Article

Simonson, W, RA Hauser, and AH Shapira. 2007. “Role of the Pharmacist in the Effective Management of Wearing-off in Parkinson’s Disease.”. Ann Pharmacother.

Ten-year follow-up of Parkinson’s disease patients randomized to initial therapy with ropinirole or levodopa.

Publication: Journal Article

Hauser, RA, O Rascol, AD Korczyn, Jon Stoessl, RL Watts, W Poewe, PP De Deyn, and AE Lang. 2007. “Ten-Year Follow-up of Parkinson’s Disease Patients Randomized to Initial Therapy With Ropinirole or Levodopa.”. Mov Disord.

ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

Publication: Journal Article

Olanow, CW, O Rascol, RA Hauser, PD Feigin, J Jankovic, A Lang, W Langston, et al. 2009. “ADAGIO Study Investigators. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease.”. N Engl J Med.

Placebo response in Parkinson’s disease: Comparisons among 11 trials covering medical and surgical interventions

Publication: Journal Article

Goetz, CG, J Wuu, MP McDermott, CH Adler, S Fahn, CR Freed, RA Hauser, et al. 2008. “Placebo Response in Parkinson’s Disease: Comparisons Among 11 Trials Covering Medical and Surgical Interventions”. Mov Disord.

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results

Publication: Journal Article

Investigators, The NINDS NET-PD, and RA Hauser. 2008. “A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results”. Clin Neuropharmacol.

Zydis selegiline reduces off time in Parkinson’s disease patients with motor fluctuations: A 3-month, randomized, placebo-controlled study. Movement Disorders 2004;19:426-432.

Publication: Journal Article

Waters, CH, KD Sethi, RA Hauser, E Molho, and JM Bertoni. 2004. “Zydis Selegiline Reduces Off Time in Parkinson’s Disease Patients With Motor Fluctuations: A 3-Month, Randomized, Placebo-Controlled Study. Movement Disorders 2004;19:426-432.”. Movement Disorders.

Current search

Search found 373 items
(-) USF Parkinson's Disease and Movement Disorders Center
(-) 2024

Sort by

Filter By Post Date

(-) 2024

Filter By Post Type

Filter By Other Sites

(-) USF Parkinson's Disease and Movement Disorders Center

No filters available

Filter By Taxonomy

No filters available